MedElevator Войти в исследования
← Поиск публикаций

DOI 10.31557/apjcp.2025.26.11.3931

Медицинская библиотека · Asian Pacific journal of cancer prevention : APJCP · 2025

Insights on Survival and Recurrence After Surgery in Malignant Meningiomas: A Systematic Review and Meta-Analysis.

Aman Renindra Ananda, Amelia Ria, Arqursoy Hafiz, Pramudya Hermawan, Fajri Ismail

СтатьяСистематический обзорМетаанализПеревод пока не подготовлен

Аннотация

BACKGROUND

Malignant meningiomas (WHO Grade III) are rare, aggressive tumors with poor prognosis and high recurrence rates. Gross total resection (GTR) is the preferred treatment; however, recurrence remains a challenge, especially after subtotal resection (STR). The role of adjuvant radiotherapy (RT) and chemotherapy in improving patient outcomes remains controversial. This systematic review and meta-analysis assessed the impact of surgical extent, adjuvant therapies, and prognostic factors on survival and recurrence of malignant meningiomas.

METHODS

A systematic review and meta-analysis were conducted using the PubMed, Cochrane Library, and Scopus databases. Eligible studies included retrospective and prospective cohorts, case-control studies, and clinical trials reporting the surgical extent (GTR vs. STR), adjuvant therapy, survival, and recurrence. Study quality was assessed using the Newcastle-Ottawa Scale (NOS) and Cochrane Risk of Bias Tool. Meta-analysis was performed using random- and fixed-effects models and heterogeneity was assessed using the I² statistic.

RESULTS

Sixteen studies (2,208 patients) met the inclusion criteria. The 5-year overall survival (OS) ranged from 40% to 90%, with GTR significantly improving survival (HR = 0.54, 95% CI: 0.50-0.58, p < 0.00001) [1]. Recurrence rates were lower in GTR cases (50-90% in STR). Adjuvant RT improved progression-free survival (HR = 0.36, 95% CI: 0.18-0.70) in STR patients, but its benefit post-GTR was unclear. Chemotherapy had no significant effect on patient survival [2]. Key prognostic factors included tumor location, patient age, Ki-67 index, and histology [3, 4].

CONCLUSION

GTR is the strongest predictor of long-term survival, whereas STR requires adjuvant RT for disease control. The role of chemotherapy remains uncertain, necessitating further research into targeted therapies. Standardized treatment protocols and long-term surveillance are essential to improve patient outcomes [5].

Для цитирования: Aman Renindra Ananda, Amelia Ria, Arqursoy Hafiz, Pramudya Hermawan, Fajri Ismail. Insights on Survival and Recurrence After Surgery in Malignant Meningiomas: A Systematic Review and Meta-Analysis.. Asian Pacific journal of cancer prevention : APJCP. 2025. DOI: 10.31557/apjcp.2025.26.11.3931.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.